DK0521057T3 - Farmaceutiske midler indeholdende ipriflavon, fremgangsmåde til fremstilling deraf, og relativ terapeutisk anvendelse - Google Patents

Farmaceutiske midler indeholdende ipriflavon, fremgangsmåde til fremstilling deraf, og relativ terapeutisk anvendelse

Info

Publication number
DK0521057T3
DK0521057T3 DK91906489.9T DK91906489T DK0521057T3 DK 0521057 T3 DK0521057 T3 DK 0521057T3 DK 91906489 T DK91906489 T DK 91906489T DK 0521057 T3 DK0521057 T3 DK 0521057T3
Authority
DK
Denmark
Prior art keywords
preparation
therapeutic use
pharmaceutical agents
agents containing
relative therapeutic
Prior art date
Application number
DK91906489.9T
Other languages
Danish (da)
English (en)
Inventor
Paolo Chiesi
Luciana Pavesi
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of DK0521057T3 publication Critical patent/DK0521057T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pyrane Compounds (AREA)
DK91906489.9T 1990-03-23 1991-03-19 Farmaceutiske midler indeholdende ipriflavon, fremgangsmåde til fremstilling deraf, og relativ terapeutisk anvendelse DK0521057T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19793A IT1241079B (it) 1990-03-23 1990-03-23 Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico

Publications (1)

Publication Number Publication Date
DK0521057T3 true DK0521057T3 (da) 1995-02-13

Family

ID=11161262

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91906489.9T DK0521057T3 (da) 1990-03-23 1991-03-19 Farmaceutiske midler indeholdende ipriflavon, fremgangsmåde til fremstilling deraf, og relativ terapeutisk anvendelse

Country Status (14)

Country Link
EP (1) EP0521057B1 (it)
JP (1) JPH05505800A (it)
AT (1) ATE110269T1 (it)
AU (1) AU649437B2 (it)
BR (1) BR9106272A (it)
CA (1) CA2078869C (it)
DE (1) DE69103624T2 (it)
DK (1) DK0521057T3 (it)
ES (1) ES2059130T3 (it)
HU (1) HU217431B (it)
IT (1) IT1241079B (it)
NZ (1) NZ237519A (it)
PT (1) PT97088B (it)
WO (1) WO1991014429A1 (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212932B (en) * 1993-08-02 1996-12-30 Chinoin Gyogyszer Es Vegyeszet Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5506211A (en) * 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
HU9502198D0 (en) * 1995-07-21 1995-09-28 Chinoin Gyogyszer Es Vegyeszet Novel indication
AUPO203996A0 (en) 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
US6146668A (en) 1997-04-28 2000-11-14 Novogen, Inc. Preparation of isoflavones from legumes
US6956048B2 (en) 1999-03-31 2005-10-18 Pharmacia & Upjohn Company Pharmaceutical emulsions for retroviral protease inhibitors
AUPQ266199A0 (en) 1999-09-06 1999-09-30 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
AUPR363301A0 (en) 2001-03-08 2001-04-05 Novogen Research Pty Ltd Dimeric isoflavones
EP2081570A2 (en) * 2006-10-24 2009-07-29 David W. Krempin Anti-resorptive and bone building dietary supplements and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1065M (fr) * 1964-01-02 1962-01-15 Laroche Navarron Lab Médicament a base de composés isoflavoniques pour augmenter la résistance des capillaires.
HU162377B (it) * 1970-05-27 1973-02-28
DE2631214A1 (de) * 1976-07-12 1978-01-26 Kali Chemie Pharma Gmbh Verfahren zur erhoehung der loeslichkeit von schwerloeslichen arzneistoffen zum zwecke deren applikation in gelatinekapseln
JPS59199630A (ja) * 1983-04-26 1984-11-12 Takeda Chem Ind Ltd 卵巣機能低下症治療剤
HU199444B (en) * 1985-09-10 1990-02-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 7-isopropoxy-isoflavone-cyclodextrene inclusion complex and pharmaceutical compositions therefrom
AU645003B2 (en) * 1988-11-08 1994-01-06 Takeda Chemical Industries Ltd. Sustained release preparations

Also Published As

Publication number Publication date
IT9019793A1 (it) 1991-09-23
HU9203022D0 (en) 1992-12-28
EP0521057B1 (en) 1994-08-24
JPH05505800A (ja) 1993-08-26
AU649437B2 (en) 1994-05-26
HU217431B (hu) 2000-01-28
PT97088B (pt) 1998-08-31
EP0521057A1 (en) 1993-01-07
DE69103624D1 (de) 1994-09-29
WO1991014429A1 (en) 1991-10-03
CA2078869A1 (en) 1991-09-24
HUT62471A (en) 1993-05-28
ES2059130T3 (es) 1994-11-01
PT97088A (pt) 1991-11-29
CA2078869C (en) 2003-01-28
NZ237519A (en) 1992-07-28
IT9019793A0 (it) 1990-03-23
ATE110269T1 (de) 1994-09-15
IT1241079B (it) 1993-12-29
BR9106272A (pt) 1992-12-01
AU7541491A (en) 1991-10-21
DE69103624T2 (de) 1994-12-22

Similar Documents

Publication Publication Date Title
MX9301929A (es) Derivados de pirimidina y procedimientos para su preparacion.
IS1564B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
ATE4168T1 (de) 2-phenyl-1,2-benzisoselenazol-3(2h)-one enthaltende pharmazeutische zubereitungen und ihre anwendung.
MX9300407A (es) Derivados azabiciclicos usados en la fabricacion de medicamentos, composiciones que los contienen y procedimiento para su preparacion.
IL58775A0 (en) Hydroxyethyl-azole compounds,their production and pharmaceutical compositions containing them
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
NZ192195A (en) 1-triazolyl-2-hydroxy-2-phenyl-3-aryl-propanes and pharmaceutical compositions
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
MX9203320A (es) Composicion antialergica que contiene compuestos biciclicos switterionicos.
FI913943A0 (fi) Nya kroman- och tiokromanderivat.
DK0521057T3 (da) Farmaceutiske midler indeholdende ipriflavon, fremgangsmåde til fremstilling deraf, og relativ terapeutisk anvendelse
ES2144054T3 (es) Complejos de tri(platino).
ES8306483A1 (es) Procedimiento de preparacion de las dibezooxepinas sustituidas y de sus sales de adicion con un acido mineral u organico
DK0417003T3 (da) Anvendelse af antiprogestomimetiske forbindelser til fremme af ovulation
MX9203361A (es) Composiciones farmaceuticas que contienen cloruro de galio.
ATE10841T1 (de) Tricyclische thiazolyloxamidsaeuren und derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
SE7708622L (sv) 2-bensyl-perhydroazepiner, sett for framstellning derav och lekemedel, innehallande dem
ATE106874T1 (de) Kynurensäurederivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE74505T1 (de) Schmerzpraeparat.
FR2645747B1 (fr) Nouvelles compositions pharmaceutiques, leur procede d'obtention et leur emploi en therapeutique tumorale
DE69318418T2 (de) Pharmazeutische zusammensetzungen, die 5-ht 1-rezeptoragonisten und absorptionsverstärker enthalten
IT1243368B (it) Uso del bendazac e dei suoi sali farmaceuticamente accettabili
ITMI922216A1 (it) Nitrobenzoilalanine, procedimento per la loro preparazione, loro uso come agenti terapeutici e composizioni farmaceutiche che le contengono